Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
General Physician
M.B.B.S, M.Sc. (Physiology), D.Diab.
Rheumatologist
MBBS, MRCP (UK), FCPS (Medicine), FCPS (Rheumatology)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), CEFM
Diabetologist
M.B.B.S, M.R.C.P (Ireland), M.R.C.P (Endocrinology and Diabetes - UK)
Diabetologist
M.B.B.S, M.R.C.P (Ireland), M.R.C.P (Endocrinology and Diabetes - UK)
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, FCCP, MRCP (UK), DTCD, MCPS
Diabetologist
M.B.B.S., DipDiab
Endocrinologist
MBBS, FCPS (Medicine), Fellowship in Diabetes and Endocrinology (AKU)
Endocrinologist
MBBS, FCPS (Medicine), Fellowship in Diabetes and Endocrinology (AKU)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures